IGFBP7: From Senescence Biomarker to a Vaccine for Heart Failure
- PMID: 39074184
- DOI: 10.1161/CIRCULATIONAHA.124.067059
IGFBP7: From Senescence Biomarker to a Vaccine for Heart Failure
Keywords: Editorials; heart failure; insulin-like growth factor-binding protein 7; senescence; vaccine.
Conflict of interest statement
Dr de Boer has had speaker engagements with and/or received fees from and/or served on an advisory board for Abbott, AstraZeneca, Bristol Myers Squibb, Cardior Pharmaceuticals GmbH, NovoNordisk, and Roche. Dr de Boer received travel support from Abbott, Cardior Pharmaceuticals GmbH, and NovoNordisk. Dr Aboumsallem reports no conflicts.
Comment on
-
Vaccine Therapy for Heart Failure Targeting the Inflammatory Cytokine Igfbp7.Circulation. 2024 Jul 30;150(5):374-389. doi: 10.1161/CIRCULATIONAHA.123.064719. Epub 2024 Jul 11. Circulation. 2024. PMID: 38991046
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
